Article
A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum
1 Jun 2003
Abstract excerpt
At present, the circulating bioactivity of insulin-like growth factor I (IGF-I) is estimated by immunological measurements of IGF-I levels. However, immunoassays ignore the modifying effects of the IGF-binding proteins (IGFBPs) on the interaction between IGF-I and the IGF-I receptor (IGF-IR). Therefore, we developed an IGF-I kinase receptor activation assay (KIRA) based on cells transfected with the human IGF-IR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
